Cooper C. Collins Insider Trading $TXMD TherapeuticsMD, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cooper C. Collins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cooper C. Collins. Cooper C. Collins is Director in TherapeuticsMD, Inc. ($COFF) and President and CEO in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA).
Cooper C. Collins in TherapeuticsMD, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cooper C. Collins: Director
Holdings: 92,500 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cooper C. Collins in TherapeuticsMD, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 1.45 | 47,500 | 68,875 | 140,000 | 92.5 K to 140 K (+51.35 %) |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 1.45 | 26,500 | 38,425 | 92,500 | 66 K to 92.5 K (+40.15 %) |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| May 15 2019 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 3.33 | 30,000 | 99,870 | 66,000 | 36 K to 66 K (+83.33 %) |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Mar 14 2016 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 6.23 | 16,000 | 99,717 | 36,000 | 20 K to 36 K (+80.00 %) |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 |
Page: 1